Alx Oncology Holdings Stock Technical Analysis

ALXO Stock  USD 16.22  0.72  4.65%   
As of the 25th of April, Alx Oncology shows the Downside Deviation of 5.09, mean deviation of 4.06, and Risk Adjusted Performance of 0.0521. Alx Oncology Holdings technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Alx Oncology Holdings, which can be compared to its peers. Please confirm Alx Oncology Holdings information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Alx Oncology Holdings is priced correctly, providing market reflects its regular price of 16.22 per share. Given that Alx Oncology has jensen alpha of 0.1795, we suggest you to validate Alx Oncology Holdings's prevailing market performance to make sure the company can sustain itself at a future point.

Alx Oncology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Alx, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Alx
  
Alx Oncology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Alx Oncology Analyst Consensus

Target PriceAdvice# of Analysts
17.07Strong Buy7Odds
Alx Oncology Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Alx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Alx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Alx Oncology Holdings, talking to its executives and customers, or listening to Alx conference calls.
Alx Analyst Advice Details
Alx Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alx Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alx Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Alx Oncology Holdings Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alx Oncology Holdings volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Alx Oncology Holdings Trend Analysis

Use this graph to draw trend lines for Alx Oncology Holdings. You can use it to identify possible trend reversals for Alx Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alx Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Alx Oncology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Alx Oncology Holdings applied against its price change over selected period. The best fit line has a slop of   0.04  , which may suggest that Alx Oncology Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 71.78, which is the sum of squared deviations for the predicted Alx Oncology price change compared to its average price change.

About Alx Oncology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Alx Oncology Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Alx Oncology Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Alx Oncology Holdings price pattern first instead of the macroeconomic environment surrounding Alx Oncology Holdings. By analyzing Alx Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Alx Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Alx Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.08390.0881
Price To Sales Ratio2.6K2.7K

Alx Oncology April 25, 2024 Technical Indicators

Most technical analysis of Alx help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alx from various momentum indicators to cycle indicators. When you analyze Alx charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Alx Oncology April 25, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Alx stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Alx Oncology Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alx Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alx Oncology Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alx Oncology Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Alx Stock analysis

When running Alx Oncology's price analysis, check to measure Alx Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alx Oncology is operating at the current time. Most of Alx Oncology's value examination focuses on studying past and present price action to predict the probability of Alx Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alx Oncology's price. Additionally, you may evaluate how the addition of Alx Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Alx Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.74)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.39)
Return On Equity
(0.71)
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.